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 Cancer imaging is vital for various applications in cancer treatment and research 
because it has the potential to overcome challenges within these fields. Surgical removal 
of tumors is limited by the inability to clearly assess tumor margins, but imaging can aid 
in the visualization of these margins. Cancer imaging can also help researchers see, 
monitor, and analyze the therapeutic effects of developed therapies on cancer cells. 
Currently, nanotechnology is being implemented into cancer imaging due to the potential 
to create nanoparticles designed to target cancer cells, improving the effectiveness and 
sensitivity of cancer imaging.   
 In this study, two types of supramolecular nanobeacons, SFB-K and SFB-E, were 
designed and synthesized to detect the cancer protease, cathepsin B, for cancer imaging. 
The nanobeacons were characterized by performing three different studies that 
determined how their self-assembly and cellular uptake were affected by different 
components. Nanobeacon self-assembly was studied by analyzing Transition Electron 
Microscopy (TEM) and circular dichroism (CD) time-course data of samples with 
different nanobeacon concentrations and kinetic pathways. These two studies showed that 
higher concentration and pre-existing structures induced the self-assembly of the 
nanobeacons from spherical to cylindrical nanostructures. The effect of surface charge 
and shape on nanobeacon cellular uptake was also analyzed by using flow cytometry to 
measure the cellular internalization of three sets of nanobeacons samples, SFB-K, SFB-E 
and SFB-KE, with different surface charges and shapes. The results from this study 
concluded that there is an interdependent relationship between nanobeacon surface 
charge and shape with cationic spherical nanobeacons having the highest internalization 
rates.    
 The data from these studies demonstrate how the properties of supramolecular 
nanobeacons can be tuned to optimize their performance. By defining some of the 
properties needed to reach optimal performance, future research with the SFB series 
nanobeacons involves the loading of a chemotherapy drug, such doxorubicin, onto the 
nanobeacons for more specific and effective drug delivery to cancer cells.  
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Chapter 1: Introduction 
1.1 Motivation 
According to the American Cancer Society, cancer is the second leading cause of 
death in the United States, and it is estimated that there will be close to six hundred 
thousand cancer-related deaths in 2014.
1
 One of the primary treatments for cancer is the 
surgical removal of solid tumors because the chances of survival can significantly 
increase if the entire tumor is removed.
2
 However, there are challenges involved with the 
surgical procedure. Usually, surgeons have to estimate where the margin between healthy 
and cancerous tissue lies when the difference is not apparent, and the degree of 
completeness of tumor removal is dependent on the surgeon’s ability to make this 
differentiation. This, however, can lead to the lack of removal of all the cancerous tissue, 
which is very problematic because the differentiating and metastasizing capabilities of 
the disease will facilitate its regrowth within the patient. Also, the cancer could have 
spread prior to surgery without the doctors’ knowledge, thus all the cancerous tissue is 
not removed. Cancer imaging, however, can overcome these limitations by allowing 
doctors to locate and verify where tumors are exactly located, to determine if the cancer 




Cancer imaging is very important for cancer treatment because it can also be 
applied to in vitro and in vivo research for cancer treatment. Imaging is necessary for 
cancer research because researchers need to be able to actually see the cancer cells and 
monitor the effects of the therapies being developed.
4
  By utilizing techniques that can 
result in the ability to visualize cells, cancer imaging can aid in vitro research in a variety 
of ways: research can use cancer imaging techniques to determine whether or not a 
therapy efficiently kills the cancer cells, to measure the toxicity of developed drugs, or to 
analyze differences between various therapies.
5
  
Nanotechnology is one of the emerging fields that could provide improved cancer 
imaging methods. Nanotechnology is an important field for cancer detection because 
nanotechnology applications can be used to detect cancerous tissues through the use of 
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nanoparticles, which can readily interact with biomolecules due to their size.
6 
Because 
another challenge in cancer treatment is that the cancerous tissue may be too small to be 
detected by the human eye or imaging modalities, such as MRI, nanotechnology can be 
used to over this limitations. Nanoparticles can be designed to detect cancer cells using 
cancer biomarkers, which are molecules specifically found in cancer cells, and to emit a 
signal once their targets are reached.
7
 The design of nanoparticles that can specifically 
target cancer cells can provide new methods for cancer detection that are more specific 
and sensitive to aid surgical removal and research: nanotechnological imaging technique 
can allow for the visualization of tumor margins,  for the prognosis of cancer 
aggressiveness, the prediction of the effectiveness of a particular therapy , and the 
measurement of how tumors actually respond to the therapy.
5
   
For this study, a new possible cancer detection method was developed by designing 
and synthesizing supramolecular nanoprobes to detect cathepsin B, an overexpressed 
protease in many cancers such as breast and prostate cancer. The components of the 
nanoparticles allowed them to be used as nanobeacons for the protease capable of 
emitting signals for imaging of cancer cells. Characterization studies were performed 
with the nanobeacons to determine how the self-assembly and cellular uptake of the 








Chapter 2: Background 
2.1 Molecular Beacons for the Detection of Cancer 
Relevant Enzymes 
 Molecular imaging is a research discipline currently being implemented into 
many fields because it shows great potential for many applications, such as disease 
diagnostics and therapeutics. This potential is possible because molecular imaging 
techniques allow biological processes to be noninvasively visualized, characterized, and 
measured at the molecular and cellular levels using molecular beacons.
8,9 
Molecular 
probes are key components of molecular imaging because they are designed to detect 
diseases and translate detection through imaging modalities such as optical imaging and 
magnetic resonance imaging (MRI).
10
 These probes usually contain two major parts: a 
signaling/contrast agent and a targeting moiety.
11
 The signaling/contrast agent is an 
important component of molecular probes because it produces the signal needed for 
imaging. 
9
 The signaling agent utilized determines which imaging modality is needed to 
detect the signal because different modalities require different signaling agents. For 
example, a fluorescent or bioluminescent molecule is needed for optical imaging, 
whereas single photon emission computed tomography (SPECT) requires a gamma-
emitting radionuclide.
12
 The targeting moiety of molecular probes is the component that 
interacts with a biomarker and targeting ligands, like peptides, nanoparticles, or 
antibodies, can be used for this purpose. Targets of molecular probers can be specific 
markers for biological processes or biomarkers. The protease cathepsin B is an example 
of an ideal biomarker because it is overexpressed in many cancers, such as breast and 
prostate cancer.
13
 Sometimes, a linker can be incorporated into molecular beacons to 
couple the signaling and targeting moieties and minimize interactions between the two 
that could impede signaling and targeting. The linker can affect the pharmacokinetics and 
biodistribution of the imaging probe.
11
 The different components of a molecular probe 
should work together to create an ideal probe that has high binding ability and specificity 
to its target, high sensitivity, contrast ratio, and stability, but low toxicity.
9,11
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A particular type of molecular probe that is useful for applications such as cancer 
detection is a molecular beacon, which is a single stranded hairpin shaped 
oligonucleotide probe.
14
 This probe contains the two major parts of a molecular probe, 
the signaling and targeting components, as well as a quencher.
14
 The targeting moiety 
creates the loop of the structure, and the signaling agent and quencher are localized at 
either arm of the structure. The structure is held together at the stem by two 
complementary sequences that annealed together.
15
 The signaling agent for a molecular 
beacon is a fluorophore, and the function of the quencher is to adsorb the fluorescence 
emitted from the fluorophore when the molecule is in its hairpin structure; once the target 
is reached, the target sequence hybridizes to the target, causing a conformational change 
of the structure that separates the fluorophore from the quencher, allowing it to emit light 
for detection.
16
 See Figure 2.1.  
 
 
An advantage molecular beacons have over more simple probes is that they allow more 
specific imaging of targets because they are designed to only fluoresce once they are 
hybridized by their targets.
16
  However, molecular beacons do contain some limitations; 
because their design makes it possible to reach and hybridize with their targets, it also 
leaves the beacons exposed to other molecules, not the target, that could potentially 
Figure 2.1: Molecular Beacon Concept. Molecular beacons fluoresce 
after target moiety hybridizes to target which causes a conformational 






degrade/disrupt the sequences that hold the structure together. If this occurs, false-
positive signals could arise because the quenching effect due to proximity would 
disappear.
17
 Another limitation of molecular beacons is their hydrophilic nature which 
makes cellular uptake difficult. These challenges need to be overcome in order to 
improve the efficacy of the molecular beacon system for applications such as cancer 
detection. A potential method to achieve this improvement is to incorporate this system 
with nanoparticles that could serve as platforms for the system.  
    
2.2 Self-Assembling Nanobeacons   
2.2.1 Self-Assembly of Amphiphilic Molecules 
Nanoparticles with self-assembling capabilities can be used in conjunction with 
the beacon concept, defined in section 2.1, because it can provide stability lacking in 
molecular beacons. Amphiphilic molecules are ideal compounds that can be used in the 
design of these nanoparticles because they have the capability to self-assemble into 
nanostructures that encapsulate other components, such as signaling agents, within their 
core.
18 
The main characteristic of amphiphilic molecules is that they contain a 
hydrophobic block and a hydrophilic block. The hydrophilic block can be composed of 
various materials, such as peptides and polymers.
19
 Peptides can be used as the 
hydrophilic component of amphiphilic molecules because they are biodegradable, 




Amphiphilic molecules are capable of self-assembly into nanostructures of 
different sizes and shapes due interactions driven by their hydrophobic and hydrophilic 
blocks. Through these interactions, the nanoparticles can self-assemble into 
nanostructures, such as micelles and fibers, with a hydrophobic core and hydrophilic 
outer layer.
21
 The structures and self-assembly capabilities of amphiphilic molecules 
allow for the stable incorporation of various moieties that can result on the surface of the 
nanoparticles or within the core.
12
 Due to this, by combining the concept of molecular 
beacons with amphiphilic molecules, self-assembling nanobeacons can be designed.
17
 
The number of amino acids and peptide sequence on the hydrophilic block of amphiphilic 
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molecules can affect size and shape of self-assembled nanostructure. Other factors such 
as pH, aging time, ionic strength, and temperature have also been found to affect self-
assembly by affecting inter/ intramolecular interactions.
22 
Amphiphilic molecular design 
shows great potential for various application, such as diagnosis and drug delivery, 
because various factors can be tuned and controlled to affect self-assembly and produce 
stable nanostructures.   
2.2.2 Importance of Nanoparticles Characteristics   
 Nanoparticle characteristics are important because these can significantly affect 
the performance of the nanoparticles. Some of the properties that are known to impact 
performance are shape, size, surface charge.
23
 These properties can be controlled by 
tuning the factors stated in the previous sections, such as peptide sequence and number of 
amino acids on the hydrophilic block. 
24
 Different kinetic pathways, induced through 
different solvents, aging time, and temperature, can also be employed because they can 
affect the resulting shape and size of the nanoparticles.
17
 Researchers have found that 
nanoparticles are internalized by cells through endocytotic pathways and properties such 
as shape, size, and surface charge can affect this pathway.
25
  
Shape and size can affect cellular uptake by allowing or preventing nanoparticle 
internalization through endocytosis.
 24, 26
  Endocytosis pathways have size limitations, 
and nanoparticles with sizes that exceed the limit are not able to be internalized.
26
 
Cellular uptake of nanoparticles with abnormal or elongate shapes, such as cylindrical 
nanoparticles, can also be impeded because even if their radii are within the pathway 
limitations, they can be too long for the cells to take in. Therefore, it is vital to design 
nanoparticles with sizes and shapes that do not exceed the internalization pathways’ 
limitations and researchers have found that optimal nanoparticle shape and radius for 
endocytosis are spherical nanoparticles with radii ranging between 25nm to 30nm.
25, 27
  
The surface charge of a nanoparticle can also affect cell internalization.  The cell 
membrane has a slight negative charge; therefore, charged particles have the potential to 
form electrostatic interactions with the membrane and this interaction can affect the rate 
of cellular uptake. 
28
 Previous studies have shown that cells internalized positively 
charged nanoparticles more than negatively charged ones due to possible attractive or 
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repulsive interactions, respectively, between the negatively charged cell membrane and 
the nanoparticles. 
29
 Therefore, in order to optimize nanoparticle cellular uptake, the 
design of the nanoparticles needs to incorporate moieties that result in a cationic 
nanoparticle.  






Chaper 3: Materials & Methods 
3.1 Nanobeacons Synthesis 
 The synthesis of the nanobeacons consisted of two main parts: the conjugation of 
a beacon system with a degradable linker to an amyloid-forming peptide and the 
purification of the molecules. The two following sections provide more detail about both 
of these parts.  
 
3.1.1 Peptide Synthesis  
 A Focus XC automated peptide synthesizer (AAPPTEC, Louisville, KY) was 
used to synthesize the Sup35 sequence, GNNQQNYEEE, and the enzyme degradable 
linker, GFLGK. This synthesis followed the procedure for a standard 9-
fluorenylmethoxycarbonyl (Fmoc) solid phase peptide synthesis on a 0.25mmole scale to 
produce the following peptide: Fmoc-GFLGK(Mtt) GNNQQNYXXX –Wang, where 
XXX was either lysine or glutamic acid. After this synthesis, the F-moc was removed 
with a 20% 4-methylpiperidine in DMF solution and shaken for ten minutes; this 
procedure was done twice. After the F-moc deprotection, the fluorophore 5-
carboxyfluorescein, 5-FAM, was coupled to the N-terminus of the peptide with 
5-FAM/HBTU/DIEA at a ratio of 4:4:6 relative to the peptide. After the molecule was 
shaken overnight at room temperature, the Mtt was removed with a 3%TFA, 5%TIS in 
DCM solution and shaken for five minutes; this procedure was done three times. 
Following each deprotection, the ninhydrin test (Anaspec Inc., Fremont, CA) was used to 
monitor the reactions for free amines. After the Mtt deprotection, the Black Hole 
Quencher-1, BHQ-1, was coupled to the lysine ε-amine with BHQ-1/HBTU/DIEA at a 
ratio of 1:0.96:1.7 relative to the peptide. The solution was left shaking overnight at room 
temperature; then, the peptides were cleaved from the resin solid support with a 
TFA/TIS/H2O mixture (ratio 95:2.5:2.5) for three hours. Using a rotary evaporator, the 
excess TFA was removed from the molecules and cold diethyl ether was used to 
precipitate the crude peptides in order to collect them. After collection, the nanobeacons 




 After the peptides were synthesized, they were purified by preparative RP-HPLC 
using a Varian Polymeric Column (PLRP-S, 100 Å, 10 µm, 150 × 25 mm) at 25
o
C on a 
Varian ProStar Model 325 preparative HPLC (Agilent Technologies, Santa Clara, CA) 
equipped with a fraction collector. A gradient of water and acetonitrile with 0.1 % v/v 
NH4OH was used as eluent at a flow rate of 25 mL/min and the absorbance was 
monitored at 534nm. The crude peptides were dissolved in 0.1% aqueous NH4OH, and 
each purification run was carried out with a 10 mL injection. Fractions were collected 
and analyzed by ESI-MS (LDQ Deca ion-trap mass spectrometer, Thermo Finnigan, San 
Jose, CA). A rotary evaporation was used to remove acetonitrile from the fractions 
containing the desired product, and the remaining solution was lyophilized (FreeZone -
105°C 4.5 L freeze dryer, Labconco, Kansas City, MO) and stored at -30
o
C. In order to 
check the purity of the collected fractions with the desired product, analytical reverse-
phase HPLC was performed using a Varian polymeric column (PLRP-S, 100 Å, 10 µm, 
150 × 4.6 mm) with 20 µL injection volumes.  
 
3.2 Transmission Electron Microscopy (TEM) 
TEM imaging was performed for various samples over a period of time: 
concentration dependent samples were imaged for eight days, and kinetic pathway 
dependent samples for four days. 5μL of sample was added on a carbon film copper grid 
with 400 square mesh (from EMS: Electron Microscopy Sciences) and filter paper was 
used to remove the excess in order to leave a film of sample on the grid. The sample was 
left to dry for 5 minutes; then, 5µL of 2% uranyl acetate was added to the grid, and the 
excess was again removed with filter paper. TEM imaging was done after the samples 
were left to dry for at least 2 hours.  
 
3.3 Circular Dichroism (CD) Measurements 
  CD spectra for all samples over a period of time were done on a JASCO J‐710 
spectropolarimeter (JASCO, Easton, MD). CD spectra measurements for concentration 
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dependent samples were done for eight days and four days for the kinetic pathway 
dependent samples. A 0.1mm glass cuvette was used for all samples, and the data was   
normalized using the equations below: 
θ  = θ ∙
 
 ∙ ∙  
                                             [Equation 1] 
 
θ   [deg ∙
 
    
∙







       
]                         [Equation 2]  
 
 
where θmr is the mean molar ellipticity per residue, M is the molecular weight (g/dmol), c 
is concentration (g/cm3), l is path length (cm), and nr is the number of residues. 
 
3.4 Zeta-Potential Measurements 
 Zeta-potential measurements were performed using Malvern Zetasizer Nano 
instrument and its compatible disposable capillary cell (DTS 1070 from Malvern). Water 
was added to the dilute 200µM samples to 5μM with a final volume of 1mL. The 
automated mode was used and the zeta-potential of each sample was measured three 
times in order to obtain an average and standard deviation. 
 
3.5 Flow-Cytometry Analysis  
 To study the effect of nanobeacon properties on cellular uptake, PC3-Flu cells 
were seeded onto a 24-well plate with cell density of 1x105 cells/well. After the cells 
were incubated in 37
o
C, 5% CO2 overnight, 500μL of a solution of 1640 cell medium 
containing 5µM of nanobeacons were added to the cells, and the cells were incubated for 
one hour in 37
o
C.  As controls, cells in which the energy-dependent endocytosis of the 
nanobeacons were inhibited were also prepared by pre-treating the cells with 10mM 
sodium azide and 10mM 2-deoxy-D-glucose for 15 minutes. After, the cell medium 
containing 5µM of nanobeacons was added and the cells were incubated for one hour in 
37
o
C. Cell medium was removed from both sets of cells, and 200μL of Trypsin Gibco 
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0.25% Trypsin-EDTA (1x), phenol red (Life Technologies Corporation) was added to the 
cells and incubated for two minutes at room temperature. After 500µL of 1640 cell 
medium were added to each well and the cells were re-suspended, the cells were 
transferred into 1.5mL Eppendoff tube and kept in ice. To remove the cell medium and 
wash the cells, all samples were centrifuged at 1.7k RPM for 90 seconds, the supernatant 
was removed, and 500μL of cold 1xDPBS was added. The centrifugation and supernatant 
removal was repeated once more, and then 200µL of cold 1xDPBS was added to re-
suspend the cells. The cells with the 1xDPBS were then transferred into flow-cytometry 
tubes, 10,000 of live cells were gated, and a flow-cytometer (FACSCalibur, BD) was 
used to detect the fluorescence intensity of each sample.   
12 
 
Chapter 4:  Results and Discussion 
 
4.1 Effect of Concentration on Nanobeacon Self-
Assembly 
 Two amphiphilic nanobeacons, SFB-K and SFB-E, were designed to detect the 
protease, cathepsin B, in cancer cells. The nanobeacons contained four main parts: the 
amyloid-forming peptide Sup35 with three terminal residues, lysine (SFB-K) or glutamic 
acid (SFB-E); an enzyme degradable linker; the fluorophore 5-carboxyfluorescein, 5-
FAM; and the compatible Black Hole Quencher-1, BHQ-1. See Figure 1.     
 
 
The design of the nanobeacons would allow them to self-assemble into supramolecular 
nanoprobes with the fluorescent and quencher components in the core of the 
nanostructures. The goal of these nanoprobes would be to self-assemble and remain as 
stable nanostructures that do not emit fluorescent (due to quenching effect) prior to their 
uptake by cancer cells. Once the nanoprobes have been internalized by the cells, they 
would show green fluorescence for detection from the degradation of the linker by 
cathepsin B, which would release the 5-FAM away from the quencher. As can be seen in 
Figure 4.1, SFB-K and SFB-E contained the same parts except for the terminal amino 
           
 
Figure 4.1: Chemical Structure of Nanobeacons. Sup35 peptide sequence 
composes the hydrophilic block, while the quencher, linker, and fluorophore 
compose the hydrophobic block. SFB-K contained lysine as its terminal amino 





acids. How this difference affected the performance of the nanobeacons will be discussed 
in section 4.3. 
 To study how the concentration affected the self-assembly of the nanobeacons 
into nanostructures of different shapes, SFB-K samples with different concentrations 
were prepared. Lyophilized SFB-K samples were first calibrated to 200µM in 200μL in 
HFIP (hexafluoroisopropanol), to remove pre-existing structures. After the concentration 
was calibrated, HFIP was removed from the samples, leaving the samples dry. Using 
different amounts of 25mM HEPES buffer, the samples were reconstituted to create four 
samples with concentration of 10μM, 50μM, 200μM and 600μM. Over a period eight 
days, data from the four different samples was collected using Transition Electron 
Microscopy (TEM) and cirucular dichroism (CD). Images of each sample were also taken 






















Figure 4.2: TEM Images of SFB-K Samples with Different Concentrations.  
Images correspond to days after reconstitution of samples with different 




Figure 4.2 shows that the nanobeacons first self-assembled into spherical nanostructures 
(micelles) after reconstitution, then, they transitioned into cylindrical nanostructures 
(fibers), with diameters of 9.1nm ± 3.5nm and 10.4nm ± 1.7nm, respectively. From the 
TEM images, it can be observed that concentration affects the transition from spherical to 
cylindrical nanostructures. On Day 1, all four samples predominantly contained spherical 
nanostructures (Figure 4.2a,d,g,j); the 600µM sample contained some cylindrical 
structures. By Day 4, the lower concentration samples, 10µM and 50µM, contained a 
mixture of spherical and cylindrical nanostructures (Figure 4.2b,e), but the higher 
concentration samples, 200µM and 600µM, consisted of only cylindrical structures, 
(Figure 4.2h,k). By Day 8, all four samples contained only cylindrical structures, (Figure 
4.2c,f,i,l). This study shows how the self-assembly of spherical nanostructures into 
cylindrical nanostructures is not only dependent on aging time, but also on concentration: 
higher nanobeacon concentration and longer aging time facilitate this transition. Figure 
4.2 also shows how concentration affected the viscoelastic properties of the samples: 
while all samples were fluidic at the beginning of the study, (Figure 4.2a,d,g,j),  by Day 
8, the 200µM sample became more viscous and the 600µM sample formed a rigid gel, 
(Figure 4.2i,l). The two lower concentration samples remained fluidic throughout the 
eight days, (Figure 4.2c,f).  
 In order to further study how concentration affected the self-assembly of the 
nanobeacons, circular dichroism (CD) data was recorded over eight days and the 









 Figure 4.3: CD Data of SFB-K Samples with Different Concentrations.  





As can be seen from Figure 4.3a-b, the lower concentration samples, 10μM and 
50μM, had random coil secondary structure through the course of the study, without 
significant change. The random coil signal showed a minimum peak around 200nm, 
which is due to the soluble form of Sup35 peptide. The higher concentration samples, 
however, showed a transition from a random coil signal to a beta-sheet signal, from Day 
1 to Day 4, respectively (Figure 4.3c-d). The beta-sheet signals from these samples had 
one negative and two positive peaks at around 222nm, 200nm, and 245nm respectively. 
While the first two peaks are attributed to the beta sheet secondary structure, the 245nm 
peak could be a result from the tightly packed tyrosine side chain on the surface of 
cylindrical structures from the Sup35 peptide.
30
  
By analyzing the TEM images and CD data of the samples from the beginning of 
the study, Day 1, it can be seen that when the nanobeacons adopted the random coil as 
their secondary structure, they mostly self-assembled into spherical nanostructures. When 
the samples had a strong beta-sheet signal, such as the higher concentration samples on 
Day 8, the nanobeacons formed into cylindrical nanostructures. The TEM and CD data 
demonstrate how concentration affects the nanobeacon self-assembly: higher 
concentration induces the self-assembly from spherical nanostructures with random coil 
secondary structure to cylindrical nanostructures with beta-sheet secondary structure. 
 
4.2 Effect of Kinetic Pathway on Nanobeacons 
Self-Assembly  
The self-assembly of the nanobeacons was further studied with TEM imaging and 
CD measurements using two sets of samples of the SFB-K nanobeacons prepared with 
different solvents: one set of samples contained pre-existing structures while the other set 
did not.  For the former set of samples, lyophilized SFB-K molecules were directly 
dissolved with deionized water or methanol. The other set of samples were prepared by 
pre-treating the lyophilized molecules with HFIP to break down pre-existing structures in 
the samples, and then reconstituting them with deionized water or methanol. All samples 
had a final concentration of 200µM in 200uL of solvent. Water was used as one of the 
solvents because it impedes the formation of cylindrical nanostructures by forming 
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competitive hydrogen bonds with the molecules. Methanol, on the other hand, induces 
fiber formation by strengthening the hydrogen bonds and weakening the hydrophobic 
interactions of the molecules.  After the samples were prepared, TEM imaging and CD 





As can be seen from the TEM images in Figure 4.4a-c, the sample with HFIP 
treatment started off with spherical nanostructures in Day 0 then self-assembled into 
cylindrical nanostructures by Day 2 (diameters 7.6nm ± 1.2nm and 11.6nm ± 1.3nm, 
respectively). The CD measurements of this sample also show this transition: on Day 0, 
the signal showed random coil, but by Day 2, the signals had transitioned into a beta-
sheet signal (Figure 4.4g). This change in secondary structure shows the transition from 
spherical to cylindrical nanostructure because, as previously mentioned, when the 
secondary structure was a random coil, the molecules were assembled into spherical 
nanoparticles. However, when the CD signaled a beta-sheet signal, the molecules adopted 
the cylindrical nanostructure.  Unlike the HFIP treated samples, the samples without 
Figure 4.4: TEM Images and CD Data of SFB-K Samples in Water. 
Images and graphs correspond to days after reconstitution of samples with  
water with HFIP pre-treatment (a,b,c, g) and without HFIP pre-treatment 




HFIP pretreatment contained spherical and pre-existing cylindrical structures on Day 0 
(Figure 4.4d). The transition from spherical to cylindrical nanoparticles occurred faster in 
this sample because, by Day1, this sample consisted of mainly cylindrical nanostructures. 
However, the HFIP treated sample consisted of mainly of spherical nanostructures by 
Day 1.  The Cd data for the samples without HFIP treatment also demonstrate the 
transition from spherical to cylindrical by Day 1 by showing a random coil signal on Day 
0, but a beta-sheet sheet signal in Day 1 and after(Figure 4.4h). 
 The same study was repeated using methanol as the solvent: the samples were 
prepared the same way, with or without HFIP pre-treatment, but methanol was used to 








 Unlike both samples prepared with water, the methanol samples did not show a 
transition from spherical nanostructures to cylindrical. The TEM images and CD 
measurements for the HFIP treated sample show how the nanostructures remained in 
spherical nanostructures, diameter 6.0nm ± 0.8,  with alpha-helix signal (negative peaks 
 
Figure 4.5: TEM Images and CD Data of SFB-K Samples in Methanol.  
Images and graphs correspond to days after reconstitution of samples with 
methanol with HFIP pre-treatment (a,b,c, g) and without HFIP pre-treatment 




at 208nm and 222nm) throughout the course of the study, respectively (Figure 4.5a-c,g).  
However, the sample without HFIP pre-treatment contained predominantly cylindrical 
structures, diameter 11.4nm ±1.7nm, with beta-sheet signal from Day 0 and remained 
stable throughout the four days of the study (Figure 4.5d-f,h).    
By comparing the samples with HFIP pre-treatments from those without HFIP 
pre-treatment, it can be seen that kinetic pathways involving pre-existing structures 
affected the self-assembled nanostructres and the secondary structures of the 
nanobeacons.  The pre-existing structures induced the self-assembly of cylindrical 
nanostructures. The data from Figures 4.4 and 4.5 also shows how the solvents affected 
these properties: while water enabled the transition from spherical nanostructures with 
random coil signal to cylindrical structures with beta-sheet signal, methanol did not. The 
samples prepared with water both self-assembled into cylindrical nanostructures by the 
end of the study, and the time it took for the transition to occur depended on whether or 
not the samples contained pre-existing structures. The methanol samples, however, 
contained either spherical or cylindrical structures throughout the course of the study, and 
the determinant of the structures depended on the presence of pre-existing structures.    
  
4.3 Effect of Surface Charge and Shape on 
Nanobeacon Cellular Uptake  
 The effect of surface charge and shape on nanobeacon cellular uptake was studied 
by preparing three sets of samples of nanobeacons, SFB-K, SFB-E and SFB-KE, with 
different shapes and analyzing zeta-potential and flow cytometry measurements. SFB-K 
and SFB-E lyophilized powder molecules were pre-treated with HFIP to disrupt pre-
existing structures and to calibrate the concentration of the structures to 200µM. SFB-KE 
samples were then prepared by mixing 100µL of each 200µM SFB-K and SFB-E 
samples in HFIP in a 1:1 equimolar ratio. The HFIP was then removed from the samples 
using a rotary evaporator and 25mM HEPES buffer was used to reconstitute the samples.  
Spherical and cylindrical samples for the three different nanobeacons were then prepared. 
All spherical samples, SFB-K, SFB-E and SFB-KE, were prepared by storing 
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reconstituted samples at 4
o
C after reconstitution with HEPES buffer; SFB-K and SFB-KE 
cylindrical samples were prepared by sonicating reconstituted samples for 20 minutes 
after reconstitution, then aging them for at least 3 days in room temperature.  The SFB-E 
cylindrical sample was prepared differently because HFIP treatment resulted in samples 
containing both spherical and cylindrical samples. Therefore, the SFB-E cylindrical 
sample was not pre-treated with HFIP; instead, 1xDBPS buffer was used to directly 
dissolve the lyophilized SFB-E powder molecules. All samples had a concentration of 
200µM in 200µL of solvent.  
 In order to determine the surface charge of the molecules, the zeta-potentials of 
the spherical and cylindrical samples of the SFB-K, SFB-E and SFB-KE nanobeacons 
were measured. See Table 4.1 
 
 
Nanobeacon Sample Spherical (mV) Cylindrical (mV) 
SFB-K +40.7±2.1 +42.9±0.7 
SFB-E -50.2±1.6 -61.1±6.2 
SFB-KE -30.8±1.1 -40.4±3.6 
 
 As can be seen in Table 4.1, the spherical and cylindrical samples of SFB-K had 
positive zeta-potentials of +40.7 ± 2.1 mV and +42.9 ± 0.7mV, respectively. The positive 
charge was a result from the free amines on the lysine side chains of the SFB-K 
molecules.  The spherical and cylindrical samples of SFB-E, however, had negative zeta-
potentials of -50.2 ± 1.6 mV and -61.1 ± 6.2 mV, respectively, due to the free carboxylic 
groups on the glutamic acids’ side chain and on the C-terminus of the molecule. The 
spherical and cylindrical samples of SFB-KE had negative zeta-potentials of 
 -30.8±1.1mV and -40.4±3.6mV, respectively. The net negative surface charge of the 
SFB-KE nanobeacons resulted from the mixing of the three positively charged amine 
groups of the SFB-K molecules and the four negatively charged carboxylic acid groups of 
the SFB-E molecules.   




 In order to analyze how the surface charge and shape affected the cellular uptake 
of the nanobeacons, PC3-Flu cells were treated with medium containing 5μM of each 
sample of nanobeacons. These cells, metastatic human prostate cancer cells, were used 
because they contained overexpressed concentrations of cathepsin B. After the cells were 
incubated with the nanobeacon-containing cell medium, flow cytometry readings of the 
cells were taken. Monomer samples of each nanobeacon were also prepared (with 
DMSO) and analyzed as controls in order to ensure that differences seen in cellular 
uptake were actually due to differences in surface charge and shape. Also as controls, 
samples of cells in which the energy-dependent endocytosis of the nanobeacons was 
inhibited were also prepared and analyzed. See Figure 4.6.   
 
Figure 4.6 allows the analysis of nanobeacon internalization rate because fluorescence 
detection was only possible once the nanobeacons entered the cells and cathepsin B 
cleaved the linker to release the 5-FAM from the nanoparticles. As can be seen on Figure 
4.6, the surface charge and shape of the nanobeacons significantly affected the 
nanobeacon cellular uptake. The differences seen between the monomer and the self-
assembled nanostructure samples showed that the latter were stable and did not 
 
Figure 4.6: Flow Cytometry Data of SFB-K, SFB-E and SFB-KE Nanobeacons.  
a) Graph corresponds to fluorescence intensity of nanobeacons after cellular uptake 
by PC3-Flu cells. b) Graphs correspond to flow cytometry spectra each nanobeacon 
sample.   
21 
 
disassociate prior to cellular uptake. Figure 4.6 shows that cationic SFB-K nanoparticles 
had higher internalization rates than the anionic SFB-E and SFB-KE nanoparticles, as 
was expected. This difference on cellular uptake between cationic and anionic 
nanobeacons was most like due to electrostatic interactions of the nanobeacons with the 
marginally anionic cell membrane. Figure 4.6 also shows how shape affected nanobeacon 
cellular uptake: all of the SFB-K, SFB-E and SFB-KE spherical nanobeacons had higher 
internalization rates than their cylindrical counterparts. This could be due to the fact that 
the internalization of the cylindrical nanoparticles was somewhat impeded by their 
elongated shape.  The flow cytometry data shows that the cellular uptake of the spherical 
nanobeacons was affected by surface charge: the cationic spherical nanobeacons 
fluoresced more than six times higher than the anionic ones. Unlike the spherical 
nanobeacons, the cylindrical nanobeacons were not significantly affected by surface 
charge. On the other hand, the cellular uptake of the cationic SFB-K nanobeacons was 
affected by shape: the spherical SFB-K nanobeacons fluoresced more than the cylindrical 
ones. These observations led to the conclusion that that the surface charge and shape of 
nanobeacons had an interdependent relationship, with cationic spherical nanobeacons 





Chapter 5: Conclusions  
5.1 Summary of Results 
In this study, a new method for cancer imaging was proposed by designing two 
supramolecular nanoprobes, SFB-K and SFB-E, to detect the proteolytic enzyme, 
cathepsin B. Three different experiments were conducted to determine how different 
properties affected the self-assembly and cellular uptake of the nanobeacons. 
One of the studies performed to analyze nanobeacon self-assembly involved 
doing time-course studies of samples with four different concentrations of SFB-K 
nanobeacons, 10µM, 50µM, 200µM, and 600µM. Transition Electron Microscopy 
(TEM) images and circular dichroism (CD) measurements were taken and analyzed for 
all four samples for a period of eight days. From this study, it was determined how 
concentration actually affected the self-assembly and secondary structure of the 
nanobeacons: higher concentrations of nanobeacons accelerated the self-assembly 
transition from spherical nanoparticles with random coil secondary structure to 
cylindrical nanoparticles with beta-sheet secondary structure.  
Samples with different kinetic pathways were also studied to further analyze the 
nanobeacon self-assembly. TEM imaging and CD measurements were also used for this 
analysis, however, the time period for this data was only four days.  Kinetic pathways 
that included pre-exiting structures showed to affect the transition from spherical to 
cylindrical nanobeacon self-assembly and induce a change in the nanobeacons’ secondary 
structure. Different solvents were also shown to affect self-assembly as well. Deionized 
water and methanol with and without HFIP treatment resulted in different kinetic 
pathways: three samples, the ones prepared with water with and without HFIP treatment 
and the methanol sample without HFIP allowed the self-assembly transition. However, 
the methanol sample with HFIP treatment did not allow the formation of cylindrical 
nanostructures after spherical self-assembly.  
 A study using flow cytometry reading was conducted to determine how 
nanobeacon cellular internalization was affected by surface charge and shape. Metastatic 
human prostate cancer cells, PC3-Flu cells, were cultured with three sets of nanobeacons, 
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SFB-K, SFB-E, and SFB-KE, with different surfaces charges and shapes. The results 
from this study concluded that cationic SFB-K spherical nanoparticles were internalized 
better than the other anionic, monomeric, or cylindrical nanobeacons. This showed an 
interdependent relationship between nanobeacon surface charge and shape.    
5.2 Future Work 
 This study has shown how the SFB series nanobeacons can be designed and tuned 
to detect the protease cathepsin B. These nanobeacons have potential to be used for 
cancer imaging because they can be modified to fit various environments of the body to 
effectively detect cathepsin. Future work involving the SFB series nanobeacons can lead 
towards incorporating a chemotherapy drug, such as doxorubicin within the nanobeacons. 
Drug loading into the nanobeacons would allow for the detection of cancer cells through 
cathepsin B detection, then once they have been internalized, the drug would be released 
through enzymatic degrading, killing the cells.  By loading a drug into the nanobeacons, 
they could potentially be used as theranostics nanoparticles that combine both diagnostics 
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